The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBakkavor Regulatory News (BAKK)

Share Price Information for Bakkavor (BAKK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 121.00
Bid: 117.50
Ask: 120.00
Change: 1.50 (1.26%)
Spread: 2.50 (2.128%)
Open: 117.00
High: 121.00
Low: 117.00
Prev. Close: 119.50
BAKK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission to Trading on the London Stock Exchange

16 Nov 2017 08:06

RNS Number : 6347W
Bakkavor Group PLC
16 November 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Investors should not subscribe for or purchase any ordinary shares referred to in this announcement except on the basis of information in the prospectus in its final form (the "Prospectus") published by Bakkavor Group plc (together with Bakkavor Holdings Limited and each of their subsidiaries and subsidiary undertakings, "Bakkavor" or the "Group") in connection with the admission of its ordinary shares (the "Shares") to the premium listing segment of the Official List of the FCA and to trading on London Stock Exchange plc's main market for listed securities (the "London Stock Exchange"). A copy of the Prospectus is available for inspection from the Group's website at www.bakkavor.com and from Bakkavor's registered office at Fitzroy Place, 5th Floor, 8 Mortimer Street, London W1T 3JJ.

For immediate release

16 November 2017

 

Bakkavor Group plc

Admission to Trading on the London Stock Exchange

Following its announcements on 10 November 2017, Bakkavor is pleased to announce that its entire ordinary share capital, consisting of 579,425,585 ordinary shares, has today been admitted to the premium listing segment of the Official List of the FCA and to trading on the London Stock Exchange's main market for listed securities under the ticker "BAKK".

Enquiries

Bakkavor

+44 (0) 20 7908 6135

Tamarin Bibow

HSBC (Joint Global Co-ordinator, Joint Bookrunner and Sponsor)

+44 (0) 20 7991 8888

Mark Dickenson

Paul Bundred

Kerem Akcay

Morgan Stanley (Joint Global Co-ordinator and Joint Bookrunner)

+44 (0) 20 7425 8000

Tom Perry

Imran Ansari

Martin Thorneycroft

Angus Millar

Barclays (Joint Bookrunner)

+44 (0) 20 7623 2323

Phil Shelley

Ulrich Kratz

Citi (Joint Bookrunner)

+44 (0) 20 7500 5000

Edward McBride

Christopher Wren

Peel Hunt (Joint Bookrunner)

+44 (0) 20 7418 8900

Alastair Rae

Adrian Trimmings

Rabobank (Lead Manager)

+44 (0) 20 7809 3000

Ben Davies

Willem Kroner (ECM)

Rothschild (Financial Adviser)

+44 (0) 20 7280 5000

Adam Young

Stuart Vincent

Stephen Taylor

Rupert Howard

Media Enquiries

Tulchan (public relations adviser to Bakkavor)

+44 (0) 20 7353 4200

Susanna Voyle

Will Smith

Jessica Reid

 

Important Notice

Each of HSBC Bank plc ("HSBC"), Morgan Stanley & Co. International plc ("Morgan Stanley"), Barclays Bank PLC ("Barclays") and Citigroup Global Markets Limited ("Citi"), authorised by the Prudential Regulation Authority ("PRA") and regulated by the Financial Conduct Authority ("FCA") and the PRA in the United Kingdom Coöperatieve Rabobank U.A. ("Rabobank"), authorised by De Nederlandsche Bank, Netherlands and the PRA and subject to limited regulation by the FCA and the PRA with Kepler Cheuvreux as its distribution partner, and Peel Hunt LLP ("Peel Hunt"), authorised and regulated in the United Kingdom by the FCA (collectively, the "Banks") and N M Rothschild & Sons Limited ("Rothschild"), authorised and regulated in the United Kingdom by the FCA, are acting exclusively for the Company and no-one else in connection with the Offer and will not regard any other person (whether or not a recipient of this announcement) as their respective clients in relation to the Offer and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients nor for giving advice in relation to the Offer, the contents of this announcement or any transaction, arrangement or other matter referred to herein.

This announcement is not for publication or distribution, directly or indirectly, in or into or from Australia, Canada, Japan or the United States (including its territories and possessions, any State of the United States and the District of Columbia) or any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy, securities to any person in Australia, Canada, Japan or the United States or in any jurisdiction to whom or in which such offer or solicitation is unlawful. The securities referred to herein may not be offered or sold in the United States absent registration under the US Securities Act of 1933, as amended (the "Securities Act") or another exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Subject to certain exceptions, the securities referred to herein may not be offered or sold in Australia, Canada or Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada or Japan. The offer and sale of the securities referred to herein has not been and will not be registered under the Securities Act or under the applicable securities laws of Australia, Canada or Japan. There will be no public offer of the securities in the United States.

In member states of the European Economic Area (each, a "Relevant Member State"), this announcement and any offer if made subsequently is addressed and directed only at persons who are "qualified investors" within the meaning of the Prospectus Directive ("Qualified Investors"). For these purposes, the expression "Prospectus Directive" means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in a Relevant Member State), and includes any relevant implementing measure in the Relevant Member State and the expression "2010 PD Amending Directive" means Directive 2010/73/EU. In the United Kingdom this announcement is directed exclusively at Qualified Investors (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") or (ii) who fall within Article 49(2)(A) to (D) of the Order, and (iii) to whom it may otherwise lawfully be communicated, and any investment activity to which it relates will only be engaged in with such persons and it should not be relied on by anyone other than such persons.

This announcement is not a prospectus and investors should not purchase any shares referred to in this announcement except on the basis of information in the Prospectus published by the Company in connection with the admission of the Shares to the premium listing segment of the Official List of the Financial Conduct Authority and to trading on London Stock Exchange plc's main market for listed securities. Copies of the Prospectus are available from the Company's registered office at Fitzroy Place, 5th Floor, 8 Mortimer Street, London, England, W1T 3JJ and on the Company's website at www.bakkavor.com. Any purchase of Shares in the Offer should be made solely on the basis of the information contained in the final Prospectus issued by the Company in connection with the Offer. Before investing in the Shares, persons viewing this announcement should ensure that they fully understand and accept the risks which are set out in the Prospectus. The information in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness. This announcement does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for any Shares or any other securities nor shall it (or any part of it) or the fact of its distribution, form the basis of, or be relied on in connection with, any contract therefor. The information in this announcement is subject to change. Information in this announcement or any of the documents relating to the Offer cannot be relied upon as a guide to future performance. The price and value of securities may go up as well as down. Persons needing advice should contact a professional adviser.

This announcement includes forward-looking statements, which are based on current expectations and projections about future events. These statements may include, without limitation, any statements preceded by, followed by or including words such as "target", "believe", "expect", "aim", "intend", "may", "anticipate", "estimate", "plan", "project", "will", "can have", "likely", "should", "would", "could" and other words and terms of similar meaning or the negative thereof. Forward-looking statements may and often do differ materially from actual results. These forward-looking statements are subject to risks, uncertainties and assumptions about the Company and its subsidiaries and investments, including, among other things, the development of its business, trends in its operating industry, and future capital expenditures and acquisitions. By their nature, forward looking statements involve risk and uncertainty because they relate to future events and circumstances. Any forward-looking statements reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Group's business, results of operations, financial position, prospectus, growth or strategies and the industry in which it operates. Save as required by law or by the Listing Rules of the FCA, each of the Company, the Banks, Rothschild and their respective affiliates expressly disclaims any obligation or undertaking to update, review or revise any forward looking statement contained in this announcement whether as a result of new information, future developments or otherwise. Forward-looking statements speak only as of the date they are made.

The timetable, including the date of Admission, may be influenced by a range of circumstances such as market conditions. There is no guarantee that Admission will occur and you should not base your financial decisions on the Company's intentions in relation to Admission at this stage. Acquiring investments to which this announcement relates may expose an investor to a significant risk of losing all of the amount invested. Persons considering making such investments should consult an authorised person specialising in advising on such investments. This announcement does not constitute a recommendation concerning the Offer. The value of the Shares can decrease as well as increase. Potential investors should consult a professional advisor as to the suitability of the Offer for the person concerned.

In connection with the Offer of the Shares, each of the Banks and any of their affiliates, acting as investors for their own accounts, may take up a portion of the Shares in the Offer as a principal position and in that capacity may retain, purchase, sell, offer to sell or otherwise deal for their own accounts in such Shares and other securities of the Company or related investments in connection with the Offer or otherwise. Accordingly, references in the Prospectus, once published, to the Shares being issued, offered, subscribed, acquired, placed or otherwise dealt in should be read as including any issue or offer to, or subscription, acquisition, placing or dealing by, the Banks and any of their affiliates acting in such capacity. In addition, the Banks and any of their affiliates may enter into financing arrangements (including swaps or contracts for differences) with investors in connection with which the Banks and any of their affiliates may from time to time acquire, hold or dispose of Shares. The Banks do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.

None of the Banks, Rothschild nor any of their respective affiliates or any of their respective directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for or makes any representation or warranty, express or implied, as to the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other statement made or purported to be made by it, or on its behalf, in connection with the Company, the Shares or the Offer or any other information relating to the Company, its subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith. Each of the Banks and Rothschild and each of their respective affiliates accordingly disclaim, to the fullest extent permitted by applicable law, all and any liability whether arising in tort, contract or otherwise which they might otherwise be found to have in respect of this announcement or any such statement or information. No representation or warranty express or implied, is made by any of the Banks, Rothschild or any of their respective affiliates as to the accuracy, completeness, verification or sufficiency of the information set out in this announcement, and nothing in this announcement will be relied upon as a promise or representation in this respect, whether or not to the past or future.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMMMMNKLGNZM
Date   Source Headline
11th Apr 201910:50 amRNSDirector/PDMR Shareholding
8th Apr 20193:57 pmRNSFTSE 250 movers: Saga sinks, Indivior increases
8th Apr 20197:00 amRNSAnnual Financial Report
28th Feb 20194:41 pmRNSSecond Price Monitoring Extn
28th Feb 20194:35 pmRNSPrice Monitoring Extension
28th Feb 20197:00 amRNSFinal Results
27th Feb 20194:40 pmRNSSecond Price Monitoring Extn
27th Feb 20194:35 pmRNSPrice Monitoring Extension
18th Jan 20197:00 amRNSTrading Statement
13th Dec 20184:41 pmRNSSecond Price Monitoring Extn
13th Dec 20184:36 pmRNSPrice Monitoring Extension
12th Nov 20183:07 pmRNSDirector Declaration
26th Oct 20187:00 amRNSDirector/PDMR Shareholding
6th Sep 20187:00 amRNSHalf-year Report
6th Sep 20187:00 amRNSAcquisition
12th Jul 201811:11 amRNSDirectorate Change
23rd May 20183:55 pmRNSResult of AGM
23rd May 20187:00 amRNSTrading Statement
9th May 20184:40 pmRNSSecond Price Monitoring Extn
9th May 20184:35 pmRNSPrice Monitoring Extension
10th Apr 201812:08 pmRNSDirector/PDMR Shareholding
10th Apr 201811:37 amRNSAnnual Financial Report
3rd Apr 20187:00 amRNSDirectorate Change
28th Feb 20187:00 amRNSFinal Results
18th Jan 20187:00 amRNSStatement re Broker Appointment
18th Jan 20187:00 amRNSTrading Statement
8th Dec 20177:12 amRNSHolding(s) in Company
8th Dec 20177:11 amRNSHolding(s) in Company
8th Dec 20177:10 amRNSHolding(s) in Company
8th Dec 20177:00 amRNSHolding(s) in Company
21st Nov 20172:24 pmRNSHolding(s) in Company
20th Nov 20171:46 pmRNSDirector/PDMR Shareholding
16th Nov 20178:06 amRNSAdmission to Trading on the London Stock Exchange

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.